ADAR and thyroid gland carcinoma: To test whether abnormal expression of ADAR1 in thyroid cancer cell lines affects miR-200b editing, we analyzed the miR-200b edited/WT ratio in ADAR1-silenced TPC1 and Cal62 cells, and found that the editing ratio decreased (Fig. 3c).